|
Lipella Pharmaceuticals Inc (LIPO) |
|
Lipella Pharmaceuticals Inc
LIPO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Lipella Pharmaceuticals Inc growth rates, revenue grew
by 27.89 % in II. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.17 %
Lipella Pharmaceuticals Inc net loss decreased from $-2 millions, to $-1 millions in II. Quarter 2024,
• More on LIPO's Growth
|
|
Lipella Pharmaceuticals Inc realized a net loss in trailing twelve months.
Lipella Pharmaceuticals Inc realized cash reduction of $ -0.25 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.13.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
• More on LIPO's Valuation
|
|
|
|
|
Lipella Pharmaceuticals Inc realized net loss in trailing twelve months.
Lipella Pharmaceuticals Inc realized cash outflow of $ -0.25per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.13.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
Lipella Pharmaceuticals Inc Price to Book Ratio is at 1.82 lower than Industry Avg. of 84.78. and higher than S&P 500 Avg. of 0
• More on LIPO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com